Advertisement

Author: Erica Cerutti

The House of Representatives voted 341 to 88 on Jan. 22 to pass a government funding package that includes several long-sought healthcare provisions backed by hospital and provider groups. The three-bill “minibus” is part of a broader bipartisan legislative package…

CMS and the Department of Homeland Security have entered an agreement that will enable Immigration and Customs Enforcement officials to access the personal data of the nation’s 79 million Medicaid members, according to an exclusive report from The Associated Press. …

In 2019, Medicare spent roughly $7.7 billion on 10 common diabetes drugs, including GLP-1 medications. By 2023, that amount reached $35.8 billion, marking a 364% increase, according to a new report from HHS' Office of Inspector General. 

Enhanced subsidies under the Affordable Care Act are set to expire at the end of 2025, with Democratic lawmakers racing to reach a deal with Republicans to extend the tax credits before this year's legislative session concludes.

Advertisement

The majority of ACA marketplace plans cover GLP-1 drugs approved for diabetes, though fewer than 1% of plan formularies include drugs solely approved to treat obesity, a new analysis from KFF shows. 

Wegovy was approved in March to reduce the risk of heart attack and stroke in adults with heart disease, paving the way for Medicare coverage of weight loss drugs. Now, healthcare policy experts anticipate monthly premiums for millions of Medicare…

Officials with the Biden administration met with UnitedHealth Group CEO Andrew Witty on March 12, urging the company to provide more emergency funding to healthcare providers facing significant financial disruptions from a cyberattack on its subsidiary, Change Healthcare, people familiar…

Advertisement